Key points are not available for this paper at this time.
Data on the performance of the latest-generation SAPIEN 3 Ultra RESILIA (S3UR) valve in patients who undergo transcatheter aortic valve replacement (TAVR) are scarce.
Yamamoto et al. (2024) studied this question.